From January 18, 2024 to March 31, 2024, the company has repurchased 2,476,300 shares, representing 0.27% for HKD 60.36 million. With this, the company has completed the repurchase of 2,476,300 shares, representing 0.27% for HKD 60.36 million under the buyback announced on January 19, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
36.2 CNY | -2.74% |
|
-3.49% | +3.40% |
Jun. 28 | Livzon Pharmaceutical Group Inc. Announces the Final Cash Dividend (A Shares) for 2023, Payable on 08 July 2024 | CI |
Jun. 28 | Livzon Pharmaceutical Group Cancels Repurchased Shares | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.40% | 4.07B | |
+55.47% | 809B | |
+39.01% | 624B | |
-7.68% | 351B | |
+6.15% | 289B | |
+13.19% | 240B | |
+13.76% | 220B | |
-0.33% | 219B | |
+7.33% | 166B | |
-3.42% | 157B |
- Stock Market
- Equities
- 000513 Stock
- News Livzon Pharmaceutical Group Inc.
- Tranche Update on Livzon Pharmaceutical Group Inc.'s Equity Buyback Plan announced on January 19, 2024.